Advanced search
Start date
Betweenand
Related content

DEVELOPMENT AND VALIDATION OF A PHARMACOECONOMIC TOOL FOR THE IMPLEMENTATION OF PHARMACEUTICAL CARE FOR HYPERTENSIVE PATIENTS IN THE PUBLIC HEALTH SYSTEM OF BRAZIL

Grant number: 16/03584-1
Support type:Scholarships in Brazil - Doctorate
Effective date (Start): July 01, 2016
Effective date (End): April 11, 2019
Field of knowledge:Health Sciences - Pharmacy
Principal researcher:Leonardo Régis Leira Pereira
Grantee:Maurilio de Souza Cazarim
Home Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated scholarship(s):17/21240-0 - Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the public health system, BE.EP.DR

Abstract

Systemic arterial hypertension (SAH) is a risk factor for 9.4 million deaths worldwide. In Brazil, HAS assigned an annual cost of about 1.5 billion to the Public Health System (PHS). The Pharmaceutical Care (PC) is able to avoid complications of hypertension and reduce health costs. The PC economic analysis in long-term showed that the net return on investment in this pharmaceutical practice can reach R$ 3,791,111.13 in ten years. One pharmacoeconomic tool for the implementation of the PC in the PHS was created in accordance with the methodology developed for this analysis. However, for this tool become applicable in society is necessary its development and validation. In addition, it is possible to improve it by adding the measurement of monetary return when evaluating morbidities associated complications of hypertension. This study aims to develop and validate the pharmacoeconomic tool to aid in the implementation of the PC in the PHS incorporating Human Disease Netwok to predict the epidemiological impact and return on investment of this pharmaceutical practice. This is a pharmacoeconomic study with application of modeling, nested in a systematic review. The data of the systematic review will be tabulated and applied in the restructuring and development of pharmacoeconomic tool. Additionally, it will be structured a Markov model to project the incidence of diseases associated with complications of hypertension by proteomic studies that resorts the Human Netwok Disease. Thus, this tool will be enhanced for its validation and applicability. It is hoped that the validation of this tool to encourage the implementation of the PC in the PHS and thus improve blood pressure control rate among hypertensive patients, quality of life, reduce morbidities and deaths associated with SAH, reduce spending with indirect costs to health, as well as assisting in the planning and optimization of health resources. There is also the pretension to foster a possible subarea in pharmacoeconomics with the use of proteomics.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CAZARIM, MAURILIO DE SOUZA; DOS REIS, TIAGO MARQUES; COELHO DA CRUZ-CAZARIM, ESTAEL LUZIA; LEIRA PEREIRA, LEONARDO REGIS. Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care. Brazilian Journal of Pharmaceutical Sciences, v. 56, 2020. Web of Science Citations: 0.
JOÃO PAULO VILELA RODRIGUES; MAURÍLIO DE SOUZA CAZARIM; SILVANA GAMA FLORENCIO CHACHÁ; ANA DE LOURDES CANDOLO MARTINELLI; LEONARDO RÉGIS LEIRA PEREIRA. Cost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis C. Cadernos de Saúde Pública, v. 36, n. 2, p. -, 2020. Web of Science Citations: 0.
MAURILIO DE SOUZA CAZARIM; JOÃO PAULO VILELA RODRIGUES; PRISCILA SANTOS CALCINI; THOMAS R. EINARSON; LEONARDO RÉGIS LEIRA PEREIRA. Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital. Revista de Saúde Pública, v. 54, p. -, 2020. Web of Science Citations: 0.
CRUZ-CAZARIM, ESTAEL L. C.; CAZARIM, MAURILIO S.; OGUNJIMI, ABAYOMI T.; PETRILLI, RAQUEL; ROCHA, EDUARDO M.; LOPEZ, V, RENATA F. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v. 140, p. 1-10, JUL 2019. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.